Immunoprotein Diagnostic Testing MarketSize and Trends

High prevalence rates of chronic diseases to push the sales of the global immunoprotein diagnostic testing market

The prime reason for the growth in the demand for immunoprotein diagnostic testing services is the increase in prevalence and incidence rate of chronic diseases. According to WHO, the Global Health Observatory (GHO) data suggests that around 1.6 million which accounts up to 2.8% of the total deaths are caused due to diabetes. Moreover, in 2012, lung cancer alone was responsible to cause about 1.6 million deaths according to the statistics mentioned in the WHO report. To prevent such high mortality rates due to chronic disorders demands early diagnosis and suitable diagnostic testing. This is where the global immunoprotein diagnostic testing can serve a massive population thereby fueling its own growth at the global level.

The chemiluminescent segment exhibits a rapid growth in the global immunoprotein diagnostic testing that can be attributed to the wide scope of application and ease of use

Based on geographical regions, the global immunoprotein diagnostic market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the major share in the global immunoprotein diagnostic testing market and is also expected to dominate the market over the forecast period, owing to higher adoption rates for technologically advanced devices and well-established healthcare infrastructures. However, Asia Pacific is expected to exhibit rapid projecting growth due to an increase in healthcare and diagnostic services demand, an increase in per capita income and improvement in the healthcare facilities.

Increase in geriatric population coupled with a high prevalence of non- communicable diseases responsible to propel the global immunoprotein diagnostic testing market

The major factors responsible to drive the global immunoprotein diagnostic testing market are the rise in the geriatric population and the high prevalence and incidence rates of chronic diseases. According to WHO, the number of people suffering from Diabetes has risen from 108 million in 1980 to 422 million in 2014, suggesting a rapid rise in the prevalence and incidence of diabetes. Moreover, according to Global Health Observatory data published by WHO in 2017, around 70% of global deaths accounting for up to 39.5 million are caused due to non- communicable diseases (NCD) such as cardiovascular diseases, chronic lung diseases, cancers, and diabetes.

In addition to this, several other drivers of the global immunoprotein diagnostic testing market comprise of awareness among population towards early diagnosis, well- established healthcare systems and the rise in the incidence of infectious diseases in the developing countries due to unhygienic conditions. However, the small shelf life of the products and low per capita income in various countries are dampening the market growth.

Immunoprotein Diagnostic Testing Market- Trends

The increasing application of immunoprotein diagnostic testing across various sectors, including oncology and infectious disease testing, indicates the evolving nature of the market. The demand for rapid diagnostic solutions in emerging economies is set to shape the growth trajectory of the global immunoprotein diagnostic testing market. Technological advancements in this domain are further opening new avenues, driving both innovation and adoption.